Developmental impact of a familial GABAA receptor epilepsy mutation
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective: A major goal of epilepsy research is to understand the molecular and functional basis of seizure genesis. A human GABA A γ2 gene mutation (R43Q) is associated with generalized epilepsy. Introduction of this mutation into a mouse by gene targeting recapitulates the human phenotype demonstrating a strong genotype to phenotype link. GABA A receptors play a role in the moment‐to‐moment control of brain function and also on the long‐term wiring of the brain by directing neuronal development. Our objective was to determine whether developmental expression of the mutation alters seizure susceptibility later in life. Methods: A tetracycline‐based conditional model for activation of a hypomorphic Q43 disease allele was created and validated. Seizure susceptibility was assessed using the subcutaneous pentylenetetrazole model. Results: Seizure susceptibility was significantly reduced in mice where the Q43 allele was suppressed during development. Interpretation: These results demonstrate that a human epilepsy‐causing mutation impacts network stability during a critical developmental period. These data suggest that identification of presymptomatic children may provide a window for therapeutic intervention before overt symptoms are observed, potentially altering the course of epileptogenesis. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“In this study, we created a mouse model in which Q43 disease allele expression is regulated using a tetracycline-controlled conditional system.(19) Reduced expression of the Q43 disease allele during early development (inception to P21) significantly reduced seizure susceptibility.”
MethodControl of memory formation through regulated expression of a CaMKII transgene
Mayford, M., Bach, M. E., Huang, Y.-Y., Wang, L., Hawkins, R. D., & Kandel, E. R. (1996) · Science · doi:10.1126/science.274.5293.1678 · Cited by 1,550
Giant synaptic potentials in immature rat CA3 hippocampal neurones.
Ben‐Ari, Y., Cherubini, E., Corradetti, R., & Gaiarsa, J. L. (1989) · The Journal of Physiology · doi:10.1113/jphysiol.1989.sp017762 · Cited by 1,317
Schwenk, F., Baron, U., & Rajewsky, K. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.24.5080 · Cited by 1,289
Developing networks play a similar melody
Ben-Ari, Y. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01813-0 · Cited by 614 · cited 1×
“2 Toward the final phases of neuronal development when networks are formed, spontaneous neuronal oscillations are thought to mediate the functional and structural maturation of neuronal networks.(23) Giant depolarizing potentials (GDP) are such oscillations seen in the hippocampus and are mediated by the excitatory GA…”
BackgroundLeinekugel, X., Medina, I., Khalilov, I., Ben-Ari, Y., & Khazipov, R. (1997) · Neuron · doi:10.1016/s0896-6273(00)80265-2 · Cited by 407
Garaschuk, O., Hanse, E., & Konnerth, A. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.219bu.x · Cited by 348
Cited by
Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies
Oyrer, J., Maljevic, S., Scheffer, I. E., Berkovic, S. F., Petrou, S., & Reid, C. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014456 · Cited by 315
Self-citationMutations in GABAAreceptor subunits associated with genetic epilepsies
Macdonald, R. L., Kang, J.-Q., & Gallagher, M. J. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.186999 · Cited by 262
Identification of new epilepsy treatments: Issues in preclinical methodology
Galanopoulou, A. S., Buckmaster, P. S., Staley, K. J., Moshé, S. L., Perucca, E., Engel, J., Löscher, W., Noebels, J. L., Pitkänen, A., Stables, J., et al. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03391.x · Cited by 261
Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum
Guerrini, R., Conti, V., Mantegazza, M., Balestrini, S., Galanopoulou, A. S., & Benfenati, F. (2023) · Physiological Reviews · doi:10.1152/physrev.00063.2021 · Cited by 196
“Neonatal” NaV1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour
Gazina, E. V., Leaw, B. T. W., Richards, K. L., Wimmer, V. C., Kim, T. H., Aumann, T. D., Featherby, T. J., Churilov, L., Hammond, V. E., Reid, C. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu562 · Cited by 89
Self-citation
Metadata
- Authors
- Chiu, C., Reid, C. A., Tan, H. O., Davies, P. J., Single, F. N., Koukoulas, I., Berkovic, S. F., Tan, S., Sprengel, R., Jones, M. V., & Petrou, S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-09-28
- Volume
- 64
- Issue
- 3
- Pages
- 284-293
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2069836023
- Cited by
- 63
- References
- 7
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Developmental impact of a familial GABAA receptor epilepsy mutation. https://app.cochat.ai/papers/10.1002/ana.21440
- The paper
- Chiu, C., Reid, C. A., Tan, H. O., Davies, P. J., Single, F. N., Koukoulas, I., Berkovic, S. F., Tan, S., Sprengel, R., Jones, M. V., & Petrou, S. (2008). Developmental impact of a familial GABAA receptor epilepsy mutation. Annals of Neurology. https://doi.org/10.1002/ana.21440
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.